Cetuximab in Third Line for Mutant APC, TP53 and RAS Patients With Refractory Metastatic Colorectal Cancer
Clinical trial NCT04853043 · TERMINATED
Trial details
- NCT number
- NCT04853043
- Sponsor
- University of Utah
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-03
- Primary completion
- 2024-02-20
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.